Item 7.01 Regulation FD Disclosure.

Aridis Pharmaceuticals, Inc. plans to make presentations to investors with the Corporate Presentation furnished as Exhibit 99.1 to this Form 8-K.

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

Item 9.01. Financial Statements and Exhibits






(d) Exhibits.



  99.1     Corporate Presentation of Aridis Pharmaceuticals, Inc.

  104    Cover Page Interactive File (the cover page tags are embedded within the
         Inline XBRL document)




                                      -2-

© Edgar Online, source Glimpses